KLRG1, identified as a co-inhibitory receptor for natural killer (NK) cells and antigen-experienced T cells, has been implicated in immune regulation in patients with non-small cell lung cancer. This evidence concerns the gene KLRG1 and non-small cell lung carcinoma.